Enterococcal superinfection and colonization with aztreonam therapy.
作者信息
Chandrasekar P H, Smith B R, LeFrock J L, Carr B
出版信息
Antimicrob Agents Chemother. 1984 Aug;26(2):280-2. doi: 10.1128/AAC.26.2.280.
Abstract
Patients were given aztreonam (SQ 26,776) parenterally for the treatment of various gram-negative infections. During or shortly after therapy, 8 (17.8%) of 45 patients became infected with or colonized by enterococcus. These eight cases included eight urinary tract isolates; one of these cases subsequently developed bacteremia. Five patients required further antimicrobial therapy directed against enterococcus. Patients receiving aztreonam are at risk for the development of enterococcal superinfection or colonization.
摘要
相似文献
1
Enterococcal superinfection and colonization with aztreonam therapy.
Antimicrob Agents Chemother. 1984 Aug;26(2):280-2. doi: 10.1128/AAC.26.2.280.
2
Evaluation of aztreonam in the treatment of severe bacterial infections.氨曲南治疗严重细菌感染的评估。
Antimicrob Agents Chemother. 1985 Aug;28(2):222-6. doi: 10.1128/AAC.28.2.222.
3
Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Rev Infect Dis. 1991 May-Jun;13 Suppl 7:S648-51. doi: 10.1093/clinids/13.supplement_7.s648.
4
Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Am J Med. 1985 Feb;78(2):251-61. doi: 10.1016/0002-9343(85)90435-8.
5
[Evaluation of azthreonam in the treatment of severe infections: study of 17 cases].
Med Clin (Barc). 1985 Jun 8;85(2):58-60.
6
Enterococcal superinfection in patients treated with ciprofloxacin.
J Antimicrob Chemother. 1988 Jan;21(1):113-5. doi: 10.1093/jac/21.1.113.
7
Treatment of gram-negative infections with aztreonam.
Am J Med. 1985 Feb 8;78(2A):27-30. doi: 10.1016/0002-9343(85)90199-8.
8
Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
J Antimicrob Chemother. 1989 May;23(5):753-8. doi: 10.1093/jac/23.5.753.
9
Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Am J Med. 1985 Feb 8;78(2A):57-64. doi: 10.1016/0002-9343(85)90206-2.
10
Pathogenicity of the enterococcus in surgical infections.肠球菌在外科感染中的致病性。
Ann Surg. 1990 Aug;212(2):155-9. doi: 10.1097/00000658-199008000-00007.
引用本文的文献
1
Comparative activity of daptomycin and teicoplanin against enterococci isolated from blood and urine.达托霉素和替考拉宁对从血液和尿液中分离出的肠球菌的比较活性。
Can J Infect Dis. 1992 Jul;3(4):173-8. doi: 10.1155/1992/257026.
2
Respiratory superinfections after the use of third-generation cephem antibiotics.
Infection. 1985;13 Suppl 1:S89-95. doi: 10.1007/BF01644226.
3
Effect of aztreonam on the colon microflora in patients undergoing colorectal surgery.
Infection. 1985 May-Jun;13(3):111-4. doi: 10.1007/BF01642868.
4
Aztreonam treatment of gram-negative septicemia.氨曲南治疗革兰氏阴性菌败血症。
Antimicrob Agents Chemother. 1986 Feb;29(2):359-61. doi: 10.1128/AAC.29.2.359.
5
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.A-56619（二氟沙星）和A-56620的体内评估：新型芳基氟喹诺酮类药物
Antimicrob Agents Chemother. 1986 Feb;29(2):201-8. doi: 10.1128/AAC.29.2.201.
6
Enterococcal urinary tract infections in a teaching hospital.
Eur J Clin Microbiol. 1987 Oct;6(5):574-5. doi: 10.1007/BF02014250.
7
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.卡芦莫南（Ro 17 - 2301；AMA - 1080）与庆大霉素治疗复杂性尿路感染的比较。
Antimicrob Agents Chemother. 1988 Apr;32(4):473-6. doi: 10.1128/AAC.32.4.473.
8
Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice.克林霉素和甲硝唑对小鼠肠球菌肠道定植及移位的影响。
Antimicrob Agents Chemother. 1988 Dec;32(12):1769-75. doi: 10.1128/AAC.32.12.1769.
9
Impact of LY146032 on Streptococcus (Enterococcus) faecalis translocation in mice.LY146032对小鼠粪肠球菌移位的影响。
Antimicrob Agents Chemother. 1988 Mar;32(3):337-40. doi: 10.1128/AAC.32.3.337.
10
The life and times of the Enterococcus.肠球菌的生存与时代
Clin Microbiol Rev. 1990 Jan;3(1):46-65. doi: 10.1128/CMR.3.1.46.
本文引用的文献
1
Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects.
J Antimicrob Chemother. 1981 Dec;8 Suppl E:131-40. doi: 10.1093/jac/8.suppl_e.131.
2
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.SQ 26776：体外抗菌活性及对β-内酰胺酶的敏感性
J Antimicrob Chemother. 1981 Dec;8 Suppl E:103-10. doi: 10.1093/jac/8.suppl_e.103.
3
Monobactams--monocyclic beta-lactam antibiotics produced by bacteria.单环β-内酰胺类抗生素——由细菌产生的单环β-内酰胺抗生素。
J Antimicrob Chemother. 1981 Dec;8 Suppl E:1-16. doi: 10.1093/jac/8.suppl_e.1.
4
Pharmacokinetics and tissue penetration of azthreonam.氨曲南的药代动力学及组织穿透性。
Antimicrob Agents Chemother. 1982 Dec;22(6):969-71. doi: 10.1128/AAC.22.6.969.
5
Antibacterial activity of a monocyclic beta-lactam SQ 26,776.单环β-内酰胺SQ 26,776的抗菌活性
J Antimicrob Chemother. 1981 Dec;8 Suppl E:111-22. doi: 10.1093/jac/8.suppl_e.111.
6
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.新型广谱抗生素羟羧氧酰胺菌素治疗后肠球菌的二重感染与定植
Ann Intern Med. 1981 Jun;94(6):784-5. doi: 10.7326/0003-4819-94-6-784.
7
Enterococcal infections in patients treated with moxalactam.接受羟羧氧酰胺菌素治疗患者的肠球菌感染
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S708-11. doi: 10.1093/clinids/4.supplement_3.s708.
8
Antibiotic-induced suprainfection.
J Infect Dis. 1969 Jun;119(6):662-5. doi: 10.1093/infdis/119.6.662.
9
Colonization, suprainfection and superinfection: major microbiologic and clinical problems.
Mt Sinai J Med. 1977 Jan-Feb;44(1):100-12.
Zotero 插件